Ilika puts Stereax in front of medical device buyers

Ilika Plc

Ilika’s Stereax solid state batteries will be represented by Cirtec Medical at MEDevice Silicon Valley on 18 and 19 November 2026.

The event is focused on medical device development, making it a relevant venue for Stereax. The audience includes engineers, R&D teams, purchasing professionals and senior decision-makers involved in bringing medical technologies to market.

Ilika is putting Stereax in front of the people who assess, design and source components for medical devices. That supports commercial visibility in a market where small size, reliability and integration matter.

Cirtec Medical’s role is also relevant. Its presence gives Stereax a route into targeted discussions with medical device companies, rather than broader or less focused investor-facing promotion.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Search